AA
IONS icon

Ancora Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Ancora Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$180K Buy
2,391
+49
+2% +$3.87K ﹤0.01% 739
2025
Q4 		$185K Buy
2,342
+205
+10% +$15.4K ﹤0.01% 758
2025
Q3 		$140K Buy
2,137
+137
+7% +$6.69K ﹤0.01% 794
2025
Q2 		$79K Hold
2,000
– – ﹤0.01% 923
2025
Q1 		$60.3K Buy
+2,000
New +$65.5K ﹤0.01% 967

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ancora Advisors's IONS Position: Q1 2026 in Review

Ancora Advisors increased its Ionis Pharmaceuticals (IONS) stake by 2.1% in Q1 2026, buying an estimated $3.87K and bringing the position to 2,391 shares worth $180K. The position accounts for ﹤0.01% of the portfolio, ranked #739.

Ancora Advisors first reported a position in IONS in Q1 2025 and has held it in 5 quarters since. The position peaked at $185K in Q4 2025. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Ancora Advisors held 2,391 shares of Ionis Pharmaceuticals worth $180K as of Q1 2026.
  • Ancora Advisors bought 49 Ionis Pharmaceuticals shares in Q1 2026, an estimated $3.87K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Ancora Advisors's portfolio in Q1 2026, its #739 holding.
  • Ancora Advisors first reported a position in Ionis Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Ancora Advisors's Ionis Pharmaceuticals position peaked at $185K in Q4 2025.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.